Screener
Recursion Pharmaceuticals, Inc. RXRX Business Segments — Income Tax Expense (Benefit)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (134,968) | (176,227) | (263,472) | (367,595) |
| Other income (loss), net | 3,962 | 4,330 | 10,359 | (6,947) |
| Loss before income tax benefit | (131,006) | (171,897) | (253,113) | (374,542) |
| Income tax benefit | 1 | — | 4,604 | 158 |
| Net loss | $(131,005) | $(171,897) | $(248,509) | $(374,384) |
| Per share data | ||||
| Net loss per share of Class A, B and Exchangeable common stock, basic and diluted | $(0.25) | $(0.41) | $(0.47) | $(0.91) |
| Weighted-average shares (Class A, B and Exchangeable) outstanding, basic and diluted | 532,460,085 | 417,361,147 | 530,890,753 | 410,268,199 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s business segments — income tax expense (benefit)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported business segments — income tax expense (benefit) of -$1K in Q2 2026.
- What does business segments — income tax expense (benefit) mean?
- This metric represents the total income tax provision or benefit allocated to the specific business segment during the reporting period. It reflects the tax impact of the segment's operational results, accounting for jurisdictional tax laws and deferred tax adjustments. Investors use this to understand the tax efficiency and fiscal obligations associated with the segment's distinct business activities.
Ask your AI about Recursion Pharmaceuticals, Inc.'s business segments — income tax expense (benefit).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude